Anti-ApoA-I IgG antibodies are not associated with carotid artery disease progression and first-time cardiovascular events in middle-aged individuals.
Jens O LagerstedtJ Dalla-RivaG MarinkovicR Del GiudiceD EngelbertsenJ BurlinJ PetrlovaM LindahlK BernfurO MelanderJan NillsonAlexandru SchiopuPublished in: Journal of internal medicine (2018)
Serum autoantibodies against ApoA-I do not correlate with disease progression and adverse events in cardiovascular disease-free individuals from the general population.